CFA
AZN icon

CT Financial Advisors’s AstraZeneca AZN Stock Holding History

CT Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$9.34K Hold
150
– – 0.01% 454
2016
Q4 		$8.2K Hold
150
– – 0.01% 462
2016
Q3 		$9.86K Hold
150
– – 0.01% 431
2016
Q2 		$9.06K Hold
150
– – 0.01% 441
2016
Q1 		$8.45K Buy
+150
New +$9.01K ﹤0.01% 466

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CT Financial Advisors's AZN Position: Q1 2017 in Review

CT Financial Advisors held its AstraZeneca (AZN) position steady in Q1 2017 at 150 shares worth $9.34K. The position accounts for 0.01% of the portfolio, ranked #454.

CT Financial Advisors first reported a position in AZN in Q1 2016 and has held it in 5 quarters since. The position peaked at $9.86K in Q3 2016. 460 funds tracked by Wall St. Rank hold AZN as of Q1 2017.

  • CT Financial Advisors held 150 shares of AstraZeneca worth $9.34K as of Q1 2017.
  • CT Financial Advisors left its AstraZeneca share count unchanged in Q1 2017.
  • AstraZeneca made up 0.01% of CT Financial Advisors's portfolio in Q1 2017, its #454 holding.
  • CT Financial Advisors first reported a position in AstraZeneca in Q1 2016 and has held it in 5 quarters since.
  • CT Financial Advisors's AstraZeneca position peaked at $9.86K in Q3 2016.
  • 460 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.